Given the major ECM component in PDAC, the predominant role of LOX family activity in organizing the ECM, and the general pro-tumor functions of LOX family proteins, we have investigated its role in PDAC chemoresistance and its impact on gemcitabine distribution into the tumor. The gene discussed is LOX; the disease is neoplasm.